{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:02:10Z","timestamp":1790488930445,"version":"4.1.0"},"reference-count":78,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,10,2]],"date-time":"2008-10-02T00:00:00Z","timestamp":1222905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Angiogenesis, the growth of new capillary blood vessels, is a central regulator of cancer growth, and a validated target for cancer therapy. The antiangiogenic agents in clinical use target one or more cellular pathways involved in the cascade of vascular growth. In haematological malignancies, angiogenesis occurs within a bone marrow ecosystem comprised of closely apposed malignant cells, endothelial cells, pericytes, fibroblasts, endothelial progenitor cells, dendritic cells, and extracellular matrix. Inhibition of angiogenesis therefore blocks not only the delivery of oxygen and micronutrients to cancer cells, but also disrupts the interdependency of these cellular players and the paracrine effects they exert to maintain the malignant phenotype. Agents such as thalidomide, lenalidomide, bortezomib, and bevacizumab, have demonstrated clinical activity in myeloma, myelodysplastic syndrome, and leukaemias. In leukaemia, vascular endothelial growth factor (VEGF) is emerging as a compelling biological target for therapy, as well as a potential predictive marker for disease relapse. Initial clinical studies suggest that the anti\u2010VEGF strategies may advance the primary, sequential or adjunctive treatment for leukaemia, and establish the basis for other potential antiangiogenic strategies in haematological malignancies.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2008.07372.x","type":"journal-article","created":{"date-parts":[[2008,10,2]],"date-time":"2008-10-02T13:12:27Z","timestamp":1222953147000},"page":"622-631","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Antiangiogenesis in haematological malignancies"],"prefix":"10.1111","volume":"143","author":[{"given":"William W.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Hutnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Gehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,11,11]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.11.3717"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10900"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701861686"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4626"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1140"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.158"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.2.492"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701573208"},{"key":"e_1_2_10_10_1","first-page":"728","article-title":"Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies","volume":"59","author":"Bellamy W.T.","year":"1999","journal-title":"Cancer Research"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.5.1427"},{"key":"e_1_2_10_12_1","first-page":"2856","article-title":"Vascular endothelial growth factor secretion is an independent prognostic factor for relapse\u2010free survival in pediatric acute myeloid leukemia patients","volume":"8","author":"De Bont E.S.","year":"2002","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.9.4082"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.7.2532"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070594"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2006.11.006"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M700563200"},{"key":"e_1_2_10_18_1","first-page":"588","article-title":"Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells","volume":"10","author":"Drexler H.G.","year":"1996","journal-title":"Leukemia"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1010"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-12-130120"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1381"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.6.1870"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-2998"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-05-1846"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197111182852108"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2006.09.048"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1616197"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-3-16"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-002-0397-4"},{"key":"e_1_2_10_30_1","first-page":"23","article-title":"The emerging role of angiogenesis inhibitors in hematologic malignancies","volume":"16","author":"Giles F.J.","year":"2002","journal-title":"Oncology (Williston Park)"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.2174\/156652405774641034"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20187"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.1.309"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0170"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-03-0627"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06539.x"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.2174\/138945007779940089"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06700.x"},{"key":"e_1_2_10_39_1","first-page":"3381","article-title":"Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real\u2010time quantitative polymerase chain reaction","volume":"7","author":"Koomagi R.","year":"2001","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.6-suppl_5-24"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041668"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061292"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0358"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22570"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986707781368423"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-078139"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.8.2637"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0610477104"},{"key":"e_1_2_10_49_1","first-page":"815","article-title":"Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia","volume":"150","author":"Perez\u2010Atayde A.R.","year":"1997","journal-title":"American Journal of Pathology"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2909"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6693515"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/bies.20655"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22398"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1089\/152581602753448522"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.0221"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.1853"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-06-2494"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0996"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1372"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404213"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-1195"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-06-0048"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1634"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404947"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770000236"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-120576"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2007.01892.x"},{"key":"e_1_2_10_68_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199911183412102"},{"key":"e_1_2_10_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03703"},{"key":"e_1_2_10_70_1","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000077043"},{"key":"e_1_2_10_71_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402330"},{"key":"e_1_2_10_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb08304.x"},{"key":"e_1_2_10_73_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701534424"},{"key":"e_1_2_10_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2006.01.013"},{"key":"e_1_2_10_75_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.6.2265"},{"key":"e_1_2_10_76_1","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1200\/jco.2006.24.18_suppl.7522","article-title":"Comparison of lenalidomide in combination with dexamethasone to dexamethasone alone in patients who have received prior thalidomide in relapsed or refractory multiple myeloma","volume":"24","author":"Wang M.","year":"2006","journal-title":"Journal of Clinical Oncology (Meeting Abstracts)"},{"key":"e_1_2_10_77_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070596"},{"key":"e_1_2_10_78_1","first-page":"835","article-title":"Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenografts","volume":"2","author":"Williams S.","year":"2003","journal-title":"Molecular Cancer Therapeutics"},{"key":"e_1_2_10_79_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404632"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2008.07372.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2008.07372.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T01:33:36Z","timestamp":1695951216000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2008.07372.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,11]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["10.1111\/j.1365-2141.2008.07372.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07372.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,11]]},"assertion":[{"value":"2008-11-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}